Microbot Medical Inc.
NCM: MBOTLive Quote
📈 ZcoreAI Score
Our AI model analyzes Microbot Medical Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get MBOT Z-Score →About Microbot Medical Inc.
Healthcare
Medical Instruments & Supplies
Microbot Medical Inc. is a medical device company that focuses on transforming endovascular procedures through advanced robotic technology. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts
📊 Fundamental Analysis
Microbot Medical Inc. demonstrates a profit margin of 0.0%, which is below the sector average, suggesting competitive pressure.
Return on Equity (ROE) is -32.4%, which indicates that capital utilization is currently under pressure.
At a current price of $2.59, MBOT currently sits at the 32nd percentile of its 52-week range (Range: $1.60 - $4.67).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
🔴
Return on Equity
Weak
⚠️
Beta (Risk)
Moderate Volatility
Key Financials
Market Cap
$173.94M
Trailing P/E
--
Forward P/E
-7.85
Beta (5Y)
1.19
52W High
$4.67
52W Low
$1.60
Avg Volume
2.05M
Day High
Day Low